Human Umbilical Cord-Derived Stem Cells: Isolation, Characterization, Differentiation, and Application in Treating...

Area of Science:

• Regenerative Medicine
• Immunology
• Endocrinology

Background:

• Stem cell therapy offers a promising avenue for diabetes treatment, leveraging the unique non-immunogenic and non-immunosuppressive properties of stem cells.
• Mesenchymal stem cells (MSCs) from human umbilical cord sources are extensively utilized in clinical cell-based therapies.
• The immunomodulatory and pro-regenerative capacities of MSCs are particularly relevant for diabetes management.

Purpose of the Study:

• This review focuses on modulating umbilical cord-derived MSCs (UCMSCs) without genetic manipulation for diabetes treatment.
• To discuss the isolation, characterization, and differentiation potential of UCMSCs.
• To explore the diverse applications of UCMSCs in treating diabetes and its complications.

Main Methods:

• Review of literature on UCMSC isolation and characterization techniques.
• Analysis of studies investigating UCMSC immunomodulatory and regenerative properties.
• Examination of preclinical and clinical data on UCMSC applications in diabetes models.

Main Results:

• UCMSCs possess intact stemness and exhibit profound effects on tissue remodeling, vascularization, and organ morphology.
• Neonatal origin of MSCs confers significant immune properties, enhancing insulin sensitivity in type 2 diabetic models.
• UCMSCs demonstrate anti-inflammatory effects, ameliorating hyperglycemia and treating complications like diabetic ulcers and impaired wound healing.
• Differentiation potential of MSCs allows for potential application in type 1 diabetes treatment, with observed reversal of hyperglycemia in animal models.

Conclusions:

• Umbilical cord-derived MSCs offer a potent, non-genetically manipulated therapeutic strategy for various forms of diabetes.
• UCMSCs hold significant potential for managing hyperglycemia, improving insulin sensitivity, and treating diabetic complications through their regenerative and anti-inflammatory actions.
• Further research into UCMSC modulation and application can advance cell-based therapies for diabetes.